Clinical Trial Update: A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

View source ↗

Summary

A multiple-dose Phase 1 study of Sinemet CR (carbidopa/levodopa) in healthy subjects to evaluate pharmacokinetics and safety; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Sinemet CR (carbidopa/levodopa)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Parkinson's Disease | Status: COMPLETED